IMCD Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/8/2026)
| Balance Sheet | Total Assets | 4,635,870,000.00 | ROE | 44.02 % |
| Balance Sheet | Total Equity | 2,040,880,000.00 | ROA | 4.69 % |
| Cashflow | Capital Expenditures | -13,037,000.00 | P/FCF | 20.02 |
| Cashflow | Free Cash Flow | 309,240,000.00 | – | – |
| Cashflow | Operating Cash Flow | 322,277,000.00 | P/CF | 19.21 |
| Income | Earnings per Share (diluted) | 3.68 | Div. Yield | 1.73 % |
| Income | Net Income | 217,577,000.00 | P/E | 28.45 |
| Income | Shares Outstanding | 59,124,000.00 | P/B | 3.03 |
| Income | Total Revenue | 4,778,870,000.00 | P/S | 1.30 |
Ratios calculated on: 10/14/2026
Company Description
IMCD N.V. markets, sells, and distributes specialty chemicals, and pharmaceutical and food ingredients in Europe, Turkey, Africa, the Asia-Pacific, and the Americas. The company offers surfactants, builders, and functional additives; excipients, active ingredients, and specialty solvents; additives, actives, and functional ingredients; and resins and binders, additives, functional fillers, pigments, and specialty solvents. It also provides texturants, proteins, flavors and colors, enzymes and cultures, natural fibers, and health ingredients; additive packages and components and base oils; monomers, process chemicals, and solvents; polymers and specialty compounds, functional additives, fillers, and reinforcements; and resins and advanced composites, and pigments. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.imcdgroup.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more